AGM Information • Apr 6, 2022
AGM Information
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 20106-29-2022 |
Data/Ora Ricezione 06 Aprile 2022 17:55:21 |
Euronext Star Milan | |
|---|---|---|---|
| Societa' | : | PHARMANUTRA | |
| Identificativo Informazione Regolamentata |
: | 159950 | |
| Nome utilizzatore | : | PHARMANUTRAN04 - Roberto Lacorte | |
| Tipologia | : | 1.1; 3.1 | |
| Data/Ora Ricezione | : | 06 Aprile 2022 17:55:21 | |
| Data/Ora Inizio Diffusione presunta |
: | 06 Aprile 2022 17:55:22 | |
| Oggetto | : | PR - PHARMANUTRA - Pubblication of list and documentation for sharelholders'meeting |
|
| Testo del comunicato |
Vedi allegato.
Pisa, 6 April 2022 – With reference to the Shareholders' Meeting of Pharmanutra S.p.A. convened for April 27, 2022 at 15:00 (the "Meeting"), it is noted that on April 1, 2022 the shareholders adhering to the Shareholders' Agreement, holders of a total of 6,292,160 shares equal to 64.99% of the subscribed and paid-up capital of Pharmanutra SpA following the list for the appointment of the supervisory body filed by them on 1 April 2022 - presented, within the terms and in the manner prescribed by law, the proposed resolutions relating to points 3.2 and 3.4 on the agenda of the 'Assembly and therefore the appointment of the Chairman of the Board of Statutory Auditors and the remuneration of the Board of Statutory Auditors.
The list presented includes the following candidates:
Candidates for the office of Standing Auditor
The list of candidates for the appointment of the members of the Board of Statutory Auditors presented by the aforementioned shareholders adhering to the Shareholders' Agreement, together with the documentation required pursuant to the law and the Articles of Association, and the proposed resolutions presented by the same shareholders are available to the public at the headquarters of the Company, in Pisa (PI), Via delle Lenze n. 216 / b, on the website at www.pharmanutra.it (Corporate Governance Section - Shareholders' Meeting), as well as at the authorized storage mechanism eMarket Storage at .
Pharmanutra S.p.A. also announces that the Directors' Report on point no. 4 of the agenda of the Shareholders' Meeting, as well as the Report on the remuneration policy and remuneration paid drawn up pursuant to Articles 123 ter of the Legislative Decree. 58/1998 and 84-quater of Consob Regulation no. 11971/1999, are available at the registered office in Pisa, via delle Lenze 216 / b, on the Company's website www.pharmanutra.it in the Governance / Shareholders' Meeting section, as well as at the authorized storage mechanism "eMarket Storage" which can be consulted at website .
The documentation referred to Art. 77, paragraph 2-bis, of Consob Regulation no. 11971/1999 will be made available to the public at the Company's registered office in accordance with the law.
Via Delle Lenze, 216/b - 56122 Pisa Tel. +39 050 7846500 [email protected]
Internal Press Office [email protected]
Via Santa Radegonda, 16 - 20121 Milan Tel. +39 02 83635708
Matteo Russo [email protected] Cristina Tronconi [email protected]
Founded and led by Chairman Andrea Lacorte and Vice Chairman Roberto Lacorte, PharmaNutra, was established in 2003; with a national widespread presence and in more than 60 countries, it develops unique nutraceuticals and innovative medical devices, overseeing the entire production process from the proprietary raw materials to the finished product. PharmaNutra is the leading producer, with the SiderAL® trademark, of iron-based nutritional supplements, a field where it holds important patents on Sucrosomial® Technology, and is regarded as one of the top emerging players in medical devices for the rehabilitation of joint capacity thanks to the Cetilar brand.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.